Takeda: Interim Phase 4 Data Support TAKHZYRO (lanadelumab) as an Effective Treatment

Press/Media

Period28 Feb 2022

Media coverage

1

Media coverage

  • TitleTakeda: Interim Phase 4 Data Support TAKHZYRO (lanadelumab) as an Effective Treatment
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date28/02/22
    PersonsPaula Busse